These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 39295845)
1. Analysis of urine cell-free DNA in bladder cancer diagnosis by emerging bioactive technologies and materials. Huang FF; Di XF; Bai MH Front Bioeng Biotechnol; 2024; 12():1458362. PubMed ID: 39295845 [TBL] [Abstract][Full Text] [Related]
2. Urinary Cell-Free DNA in Bladder Cancer Detection. Tse RT; Zhao H; Wong CY; Cheng CK; Kong AW; Peng Q; Chiu PK; Ng CF; Teoh JY Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33672869 [TBL] [Abstract][Full Text] [Related]
3. Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer. Brisuda A; Pazourkova E; Soukup V; Horinek A; Hrbáček J; Capoun O; Svobodova I; Pospisilova S; Korabecna M; Mares J; Hanuš T; Babjuk M Urol Int; 2016; 96(1):25-31. PubMed ID: 26338254 [TBL] [Abstract][Full Text] [Related]
4. Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models. Chen M; Chan RWY; Cheung PPH; Ni M; Wong DKL; Zhou Z; Ma ML; Huang L; Xu X; Lee WS; Wang G; Lui KO; Lam WKJ; Teoh JYC; Ng CF; Jiang P; Chan KCA; Chiu RWK; Lo YMD PLoS Genet; 2022 Jul; 18(7):e1010262. PubMed ID: 35793278 [TBL] [Abstract][Full Text] [Related]
5. New method to preserve the original proportion and integrity of urinary cell-free DNA. Li P; Ning J; Luo X; Du H; Zhang Q; Zhou G; Du Q; Ou Z; Wang L; Wang Y J Clin Lab Anal; 2019 Feb; 33(2):e22668. PubMed ID: 30175467 [TBL] [Abstract][Full Text] [Related]
6. Detection of the JAK2 V617F Mutation in Urinary Cell-free DNA in Patients with Myeloproliferative Neoplasms. Hosoi H; Hori Y; Fukutsuka K; Osuga M; Koh Y; Mushino T; Hanaoka N; Yamamoto N; Ohno H; Sonoki T Intern Med; 2024 Jul; 63(14):1987-1993. PubMed ID: 38008450 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria. Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Kang HW; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ Urol Oncol; 2019 Jan; 37(1):86-96. PubMed ID: 30446454 [TBL] [Abstract][Full Text] [Related]
8. Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer. Ren S; Ren XD; Guo LF; Qu XM; Shang MY; Dai XT; Huang Q J Clin Lab Anal; 2020 Aug; 34(8):e23321. PubMed ID: 32281142 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review. Koguchi D; Matsumoto K; Shiba I; Harano T; Okuda S; Mori K; Hirano S; Kitajima K; Ikeda M; Iwamura M Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012417 [TBL] [Abstract][Full Text] [Related]
10. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer. Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707 [TBL] [Abstract][Full Text] [Related]
11. Fragmentation patterns of cell-free DNA and somatic mutations in the urine of metastatic breast cancer patients. Lin S; Wang S; Xu B J Cancer Res Ther; 2024 Apr; 20(2):563-569. PubMed ID: 38454812 [TBL] [Abstract][Full Text] [Related]
12. The potential use of urine cell free DNA as a marker for cancer. Salvi S; Martignano F; Molinari C; Gurioli G; Calistri D; De Giorgi U; Conteduca V; Casadio V Expert Rev Mol Diagn; 2016 Dec; 16(12):1283-1290. PubMed ID: 27796148 [TBL] [Abstract][Full Text] [Related]
13. Concentration and integrity indexes of urine cell-free DNA as promising biomarkers for early lung cancer diagnosis. Ren S; Ren X; Guo H; Liang L; Wei K; Guo L; Qu X; Dai X; Huang Q Per Med; 2021 Mar; 18(2):129-139. PubMed ID: 33565322 [No Abstract] [Full Text] [Related]
14. Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA. Ward DG; Baxter L; Ott S; Gordon NS; Wang J; Patel P; Piechocki K; Silcock L; Sale C; Zeegers MP; Cheng KK; James ND; Bryan RT; Eur Urol Oncol; 2023 Feb; 6(1):67-75. PubMed ID: 35410825 [TBL] [Abstract][Full Text] [Related]
16. New optical imaging technologies for bladder cancer: considerations and perspectives. Liu JJ; Droller MJ; Liao JC J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis. Zancan M; Galdi F; Di Tonno F; Mazzariol C; Orlando C; Malentacchi F; Agostini M; Maran M; Del Bianco P; Fabricio AS; Murer B; Pianon C; Gion M Int J Biol Markers; 2009; 24(3):147-55. PubMed ID: 19787625 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic. Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. Laukhtina E; Shim SR; Mori K; D'Andrea D; Soria F; Rajwa P; Mostafaei H; Compérat E; Cimadamore A; Moschini M; Teoh JY; Enikeev D; Xylinas E; Lotan Y; Palou J; Gontero P; Babjuk M; Witjes JA; Kamat AM; Roupret M; Shariat SF; Pradere B; Eur Urol Oncol; 2021 Dec; 4(6):927-942. PubMed ID: 34753702 [TBL] [Abstract][Full Text] [Related]
20. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer. Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]